Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm
Portfolio Pulse from
Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) related to possible self-dealing.
January 08, 2025 | 2:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kuehn Law is investigating Syndax Pharmaceuticals for potential breaches of fiduciary duties by its officers and directors, focusing on possible self-dealing.
The investigation by Kuehn Law into potential breaches of fiduciary duties by Syndax Pharmaceuticals' officers and directors could lead to legal challenges or reputational damage, negatively impacting investor sentiment and potentially the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100